| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -21.67M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, TARA returned +23.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.8% |
| 1 year | +23.8% |
| 5 years | -54.1% |
| 10 years | -98.9% |
| All-time high | $714.40 (Jun 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in TARA would be worth today ›No. Protara Therapeutics, Inc. has not paid a dividend in the past 12 months.
Protara Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol TARA.
Protara Therapeutics, Inc. is part of the Healthcare sector.
Protara Therapeutics, Inc. has a market cap of 227.52M USD, based on the latest quote.
Protara Therapeutics, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
